Immunosensitization of Tumor Cells to Dendritic Cell-Activated Immune Responses with the Proteasome Inhibitor Bortezomib (PS-341, Velcade)

L. Y. Schumacher, D. D. Vo, H. J. Garban, B. Comin-Anduix, S. K. Owens, V. B. Dissette, J. A. Glaspy, W. H. McBride, B. Bonavida, J. S. Economou, A. Ribas
2006 Journal of Immunology  
doi:10.4049/jimmunol.176.8.4757 pmid:16585569 fatcat:4dq3qiztynfmbi4u4qh7byk75a